These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 25622539)
1. Re-purposing cryoablation: a combinatorial 'therapy' for the destruction of tissue. Baust JG; Bischof JC; Jiang-Hughes S; Polascik TJ; Rukstalis DB; Gage AA; Baust JM Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):87-95. PubMed ID: 25622539 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of cryoablation: clinical consequences on malignant tumors. Baust JG; Gage AA; Bjerklund Johansen TE; Baust JM Cryobiology; 2014 Feb; 68(1):1-11. PubMed ID: 24239684 [TBL] [Abstract][Full Text] [Related]
3. Defeating Cancers' Adaptive Defensive Strategies Using Thermal Therapies: Examining Cancer's Therapeutic Resistance, Ablative, and Computational Modeling Strategies as a means for Improving Therapeutic Outcome. Baust JM; Rabin Y; Polascik TJ; Santucci KL; Snyder KK; Van Buskirk RG; Baust JG Technol Cancer Res Treat; 2018 Jan; 17():1533033818762207. PubMed ID: 29566612 [TBL] [Abstract][Full Text] [Related]
4. Percutaneous tumor ablation: microencapsulated echo-guided interstitial chemotherapy combined with cryosurgery increases necrosis in prostate cancer. Le Pivert PJ; Morrison DR; Haddad RS; Renard M; Aller A; Titus K; Doulat J Technol Cancer Res Treat; 2009 Jun; 8(3):207-16. PubMed ID: 19445538 [TBL] [Abstract][Full Text] [Related]
5. Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer. Benzon B; Glavaris SA; Simons BW; Hughes RM; Ghabili K; Mullane P; Miller R; Nugent K; Shinder B; Tosoian J; Fuchs EJ; Tran PT; Hurley PJ; Vuica-Ross M; Schaeffer EM; Drake CG; Ross AE Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):126-136. PubMed ID: 29556048 [TBL] [Abstract][Full Text] [Related]
6. Cryoablation: physical and molecular basis with putative immunological consequences. Baust JG; Snyder KK; Santucci KL; Robilotto AT; Van Buskirk RG; Baust JM Int J Hyperthermia; 2019 Nov; 36(sup1):10-16. PubMed ID: 31795837 [TBL] [Abstract][Full Text] [Related]
7. Addition of anticancer agents enhances freezing-induced prostate cancer cell death: implications of mitochondrial involvement. Clarke DM; Baust JM; Van Buskirk RG; Baust JG Cryobiology; 2004 Aug; 49(1):45-61. PubMed ID: 15265716 [TBL] [Abstract][Full Text] [Related]
8. Integrin involvement in freeze resistance of androgen-insensitive prostate cancer. Baust JG; Klossner DP; Vanbuskirk RG; Gage AA; Mouraviev V; Polascik TJ; Baust JM Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):151-61. PubMed ID: 20066006 [TBL] [Abstract][Full Text] [Related]
9. Cryosurgery--a putative approach to molecular-based optimization. Baust JG; Gage AA; Clarke D; Baust JM; Van Buskirk R Cryobiology; 2004 Apr; 48(2):190-204. PubMed ID: 15094094 [TBL] [Abstract][Full Text] [Related]
10. T cells CD4+/CD8+ local immune modulation by prostate cancer hemi-cryoablation. Cerqueira MA; Ferrari KL; de Mattos AC; Monti CR; Reis LO World J Urol; 2020 Mar; 38(3):673-680. PubMed ID: 31263944 [TBL] [Abstract][Full Text] [Related]
11. Chemo-cryo combination therapy: an adjunctive model for the treatment of prostate cancer. Clarke DM; Baust JM; Van Buskirk RG; Baust JG Cryobiology; 2001 Jun; 42(4):274-85. PubMed ID: 11748936 [TBL] [Abstract][Full Text] [Related]
12. Targeted induction of apoptosis via TRAIL and cryoablation: a novel strategy for the treatment of prostate cancer. Clarke DM; Robilotto AT; VanBuskirk RG; Baust JG; Gage AA; Baust JM Prostate Cancer Prostatic Dis; 2007; 10(2):175-84. PubMed ID: 17297503 [TBL] [Abstract][Full Text] [Related]
13. Increased Intracellular Reactive Oxygen Species Mediates the Anti-Cancer Effects of WZ35 via Activating Mitochondrial Apoptosis Pathway in Prostate Cancer Cells. Chen M; Zhou B; Zhong P; Rajamanickam V; Dai X; Karvannan K; Zhou H; Zhang X; Liang G Prostate; 2017 Apr; 77(5):489-504. PubMed ID: 27990666 [TBL] [Abstract][Full Text] [Related]
14. Cryosurgical technique: assessment of the fundamental variables using human prostate cancer model systems. Klossner DP; Robilotto AT; Clarke DM; VanBuskirk RG; Baust JM; Gage AA; Baust JG Cryobiology; 2007 Dec; 55(3):189-99. PubMed ID: 17888898 [TBL] [Abstract][Full Text] [Related]
15. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome. Ng CK; Moussa M; Downey DB; Chin JL J Urol; 2007 Oct; 178(4 Pt 1):1253-7; discussion 1257. PubMed ID: 17698104 [TBL] [Abstract][Full Text] [Related]
16. Cryoablation induced the change of TGF-β pathway in CWR-22RV prostate cancer cell line. Nailing T; Zhi G; Xueling Y Cryobiology; 2015 Aug; 71(1):130-4. PubMed ID: 25952505 [TBL] [Abstract][Full Text] [Related]
17. Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy. Waitz R; Solomon SB; Petre EN; Trumble AE; Fassò M; Norton L; Allison JP Cancer Res; 2012 Jan; 72(2):430-9. PubMed ID: 22108823 [TBL] [Abstract][Full Text] [Related]
18. The pathophysiology of thermoablation: optimizing cryoablation. Baust JG; Gage AA; Robilottto AT; Baust JM Curr Opin Urol; 2009 Mar; 19(2):127-32. PubMed ID: 19188765 [TBL] [Abstract][Full Text] [Related]
19. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction. Jena BC; Mandal M Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188488. PubMed ID: 33271308 [TBL] [Abstract][Full Text] [Related]
20. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. Lefranc F; Rynkowski M; DeWitte O; Kiss R Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]